Home › Funds › Lone Pine Capital › ASND
Lone Pine Capital position in ASND
ASCENDIS PHARMA A/S · Health Care
Latest position (Q3 2021)1.44M sh
Reported value held$229.04M
Portfolio Weight0.77%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.44M | $229.04M | New |
Other funds holding ASND
- Fidelity Management & Research (FMR) 3.55M sh · $945.68M · Q2 2026
- BlackRock Inc 2.21M sh · $589.94M · Q2 2026
- MFS Investment Management 1.88M sh · $500.14M · Q2 2026
- Franklin Resources 1.86M sh · $496.77M · Q2 2026
- Wellington Management Group 1.55M sh · $413.05M · Q2 2026
- Capital World Investors 906.08K sh · $241.67M · Q2 2026
- Principal Global Investors 873.50K sh · $232.98M · Q2 2026
- Goldman Sachs Group 559.53K sh · $149.24M · Q2 2026
- Morgan Stanley 544.39K sh · $145.20M · Q2 2026
- Invesco Ltd 414.20K sh · $110.47M · Q2 2026
- Geode Capital Management 403.15K sh · $107.53M · Q2 2026
- UBS Group AG 401.88K sh · $107.19M · Q2 2026